Current NHS consultant posts held
Consultant Clinical Oncologist working for Maidstone and Tunbridge Wells NHS Trust at
Kent Oncology Centre, Kent & Canterbury Hospital.
Publications
Poster 3537: Intensity-Modulated Chemoradiation for Anal Cancer: A South-East UK experience. Int J Radiat Oncol Biol Phys 2020: 108(3S):e663–e664.
http://dx.doi.org/10.1016/j. ijrobp.2020.07.1983
Evolving Trends in Kidney Cancer, chap. Medical Management of Renal Cell Cancer. 10. IntechOpen, 2020
http://dx.doi.org/ 10.5772/intechopen.85931
Establishing international variation in target delineation using MRI for bladder radiotherapy. Radiother Oncol 2019: 133(Supp 1):S857–S858.
http://dx.doi.org/10.1016/S0167-8140(19)32009-2
Brachytherapy for the Urologist: A multidisciplinary team update for 2019. J Clin Urol 2019: 12(1):1–9.
http://dx.doi.org/10.1177/2051415819841703
1162 - Urinary symptoms in the first year after I-125 implantation for prostate cancer: Does 4D intraoperative dose planning improve LUTS. Eur Urol Suppl 2018: 17(2):e1637.
http:
//dx.doi.org/10.1016/S1569-9056(18)31980-8
Kent experience of radical chemoradiotherapy for muscle invasive bladder cancer. J Clin Oncol 2017: 35(Supplement 6):373.
http://dx.doi.org/10.1200/JCO.2017.35.6_ suppl.373
Chapter 43, Urological Oncology: Brachytherapy for Prostate Cancer, 743–772. Springer London, London, 2nd edn.
http://dx.doi.org/10.1007/978-0-85729-482-1_43
Does prostate HistoScanningTM play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies. BJU Int 2014: 114(4):541–548.
http: //dx.doi.org/10.1111/bju.12568
A Competing Risks Analysis of Clinical Outcomes of Prostate LDR Brachytherapy at a Single Institution. Int J Radiat Oncol Biol Phys 2014: 90(1):S415.
http://dx.doi.org/ 10.1016/j.ijrobp.2014.05.1317
Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancer. BJU Int 2013: 111(8):1181– 1182.
http://dx.doi.org/10.1111/j.1464-410X.2012.11769.x
Chapter 8, Specialist Training in Oncology: Head and Neck Cancer
http://dx.doi.org/https:// doi.org/10.1016/B978-0-7234-3458-0.00013-0
The developing role for intensity-modulated radiation therapy (IMRT) in the non-surgical treatment of brain metastases. Br J Radiol 2010: 83(986):133–136.
http://dx.doi.org/10.1259/bjr/28596848
Focal radiation therapy for patients with persistent/recurrent pituitary adenoma, despite previous radiotherapy. Pituitary 2009: 12(1):30–34.
http://dx.doi.org/10.1007/s11102-008-0115-5
